Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephen Kanes currently holds 120,000 shares of Sage Therapeutics, Inc. (SAGE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen Kanes has been a net seller of SAGE stock. They have purchased $54.0K and sold $14.5M worth of shares.
Stephen Kanes's most recent insider trade was on Feb 2, 2026, when they sold 120,000 shares at $0.00 per share.
Stephen Kanes serves as Executive at Sage Therapeutics, Inc. (SAGE). They have executed 42 insider transactions totaling $14.6M over their tenure at the company.
Stephen Kanes holds the position of Executive at Sage Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Stephen Kanes has shown a selling trading pattern, with $54.0K in total purchases and $14.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stephen Kanes was on Feb 8, 2019, when they sold $3.4M worth of SAGE shares. This transaction involved 22,948 shares at $150.00 per share.
Stephen Kanes currently owns 120,000 shares of Sage Therapeutics, Inc. (SAGE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephen Kanes's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephen Kanes has 42 Form 4 filings on record as an insider at Sage Therapeutics, Inc..
Set alerts for Stephen Kanes and 40,000+ other insiders.